B cell development and differentiation

Current Opinion in Immunology

Volumn 9, Issue 2, 1997, Pages 239-244

  Burrows, Peter D ^a   Cooper, Max D ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL; CELL SURFACE; GENE MUTATION; LYMPHOCYTOPOIESIS; REVIEW; STROMA CELL; TRANSGENE;

EID: 0030887833     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80142-2     Document Type: Article

References (62)

1. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 86:1996;897-906.
2. Cumano A, Dieterlen-Lievre F, Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell. 86:1996;907-916.
3. Nuez C, Nishimoto N, Gartland GL, Billips LG, Burrows PD, Kubagawa H, Cooper MD. B cells are generated throughout life in humans. J Immunol. 156:1996;866-872.
4. Galy A, Travis M, Cen Z, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:1995;459-473.
5. Kee BL, Paige CJ. In vitro tracking of IL-7 responsiveness and gene expression during commitment of bipotent B-cell/macrophage progenitors. Curr Biol. 6:1996;1159-1169.
6. Krop I, De Fougerolles AR, Hardy RR, Allison M, Schlissel MS, Fearon DT. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol. 26:1996;238-242.
7. Home MC, Roth PE, DeFranco AL. Assembly of the truncated immunoglobulin heavy chain Dμ into antigen receptor-like complexes in pre-B cells but not in B cells. Immunity. 4:1996;145-158.
8. of outstanding interest Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-758 A scholarly and timely review of the entire process of B cell differentiation from the earliest developmental stages to the production of high-affinity antibodies by plasma cells and the generation of memory cells.
9. of special interest Lassoued K, Illges H, Benlagha K, Cooper MD. Fate of surrogate light chains in B lineage cells. J Exp Med. 183:1996;421-429 Biosynthesis and assembly of Ig receptor components were compared in human pro-B and pre-B cell lines. The surrogate light chains in pro-B cells did not associate with either Igα or Igβ, underwent rapid degradation, and failed to reach the surface, whereas in pre-B cell lines surrogate LCs associated with μ HCs, Igα and Igβ, to form a stable receptor complex. Participants in this assembly process included BIP, calnexin, GRP94 and an unidentified Mr 17 000 protein.
10. Brouns GS, De Vries E, Neefjes JJ, Borst J. Assembled pre-B cell receptor complexes are retained in the endoplasmic reticulum by a mechanism that is not selective for the pseudo-light chain. J Biol Chem. 271:1996;19272-19278.
11. Osmond DG, Rico-Vargas S, Valenzona H, Fauteux L, Liu L, Janani R, Lu L, Jacobsen K. Apotosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow. Immunol Rev. 142:1994;209-230.
12. Karasuyama H, Rolink A, Shinkai Y, Young F, Alt FW, Melchers F. The expression of Vpre-Bλ5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell. 77:1994;133-143.
13. H rearrangement. The mechanism for this earlier than anticipated developmental block is unclear.
14. Kitamura D, Kudo A, Schaal S, Mller W, Melchers F, Rajewsky K. A critical role of the λ5 protein in B cell development. Cell. 69:1992;823-831.
15. of special interest Pelanda R, Schaal S, Torres RM, Rajewsky K. A prematurely expressed Igκ transgene, but not a VκJκ gene segment targeted into the Igκ locus, can rescue B cell development in λ5-deficient mice. Immunity. 5:1996;229-239 These studies address the potential role of a conventional κLC in rescuing B cell development in ΨLC-deficient mice. Rearranged κ transgenes efficiently rescued B cell development when the transgene was expressed early in B lineage development. Because the conventional κ chain is interchangeable with the ΨLC, recognition of the putative ligand for the pre-BCR does not depend on specificity endowed by the ΨLC component.
16. of special interest Papavasiliou F, Jankovic M, Nussenzweig MC. Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition. J Exp Med. 184:1996;2025-2030 In RAG-1/ 5 double-knockout mice, membrane μ HC transgenes were unable to promote pre-B cell progression, but either λ5 or λLC transgenes could complement this deficiency thus providing direct support for the dual pathways of early B cell development.
17. of special interest Lffert D, Ehlich A, Mller W, Rajewsky K. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity. 4:1996;133-144 This study employed single cell polymerase chain reaction analysis of VDJ rearrangements on both alleles to demonstrate allelic inclusion in early pre-B cells and allelic exclusion in B cells of λ5 knockout mice. The data indicate that pre-BCR expression can terminate the VDJ rearrangement process. Cells that pursue the alternate pathway with early LC VJ rearrangements presumably become B cells to account for the limited numbers of these cells that are generated in these mice. This paper also provides evidence for the mediation of allelic exclusion at the IgH locus by a Dμ pre-BCR.
18. H antigen specificity is involved in positive selection of pre-B cells.
19. Keyna U, Beck-Engeser GB, Jongstra J, Applequist SE, Jäck H-M. Surrogate light chain-dependent selection of Ig heavy chain V regions. J Immunol. 155:1995;5536-5542.
20. Nishimoto N, Kubagawa H, Ohno T, Gartland GL, Stankovic AK, Cooper MD. Normal pre-B cells express a receptor complex of μ heavy chains and surrogate light chain proteins. Proc Natl Acad Sci USA. 88:1991;6284-6288.
21. Lassoued K, Nuez CA, Billips L, Kubagawa H, Monteiro RC, LeBien TW, Cooper MD. Expression of surrogate light chain receptors is restricted to a late stage in pre-B-cell differentiation. Cell. 73:1993;1-20.
22. Guelpa-Fonlupt V, Tonnelle C, Blaise D, Fougereau M, Famoux F. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression. Eur J Immunol. 24:1994;257-264.
23. of special interest Winkler TH, Rolink A, Melchers F, Karasuyama H. Precursor B cells of mouse bone marrow express two different complexes with the surrogate light chain on the surface. Eur J Immunol. 25:1995;446-450 These studies in mice confirm the earlier observation in humans of low level expression of pre-B receptors on a subpopulation of pre-B cells (pre-BII). A monoclonal antibody against free λ5 protein also stained transformed and normal pro-B and pre-BI cells and precipitated surrogate LC together with a collection of other proteins ranging from Mr 30 000 to Mr 130 000 as a surrogate HC complex.
24. of special interest Kuwahara K, Kawai T, Mitsuyoshi S, Matsuo Y, Kikuchi H, Imajoh-Ohmi S, Hashimoto E, Inui S, Cooper MD, Sakaguchi N. Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase. Int Immunol. 8:1996;1273-1285 A comprehensive comparison of signal transduction for pre-BCR versus BCRs. The data indicate a characteristic signaling pattern for the pre-BCR complex that involves tyrosine phosphorylation of phosphatidylinositol-3 kinase and protein kinase C (α isoform) activation without detectable Syk activation and minimal calcium mobilization.
25. of special interest Krop I, Shaffer AL, Fearon DT, Shlissel MS. The signaling activity of murine CD19 is regulated during B cell development. J Immunol. 157:1996;48-56 This data laden paper demonstrates that murine CD19 shares with human CD19 an association with complement receptor CD21 and CD81, tyrosine phosphorylation, binding of phosphatidylinositol-3 kinase, and synergistic signaling with membrane IgM. Several other important observations are made in this paper. First, CD19 ligation does not activate calcium mobilization until the pre-B cell stage. Second, μ heavy chain transgenic products that promote pre-B cell progression in RAG-2 deficient mice cannot be seen on the cell surface by immunofluorescence but can be demonstrated functionally by the synergistic effect of anti-μ and anti-CD19 on calcium flux. Third, a μ heavy chain transgene deleted of its CH1 domain can function as a pre-BCR although it does not bind λ5.
26. of special interest Corcos D, Dunda O, Butor C, Cesbron J-Y, Lors P, Bucchini D, Jami J. Pre-B-cell development in the absence of λ5 in transgenic mice expressing a heavy-chain disease protein. Curr Biol. 5:1995;1140-1148 Expression of a truncated μ heavy chain transgene allowed pre-B cell progression in SCID mice. Interestingly, mutant μ HC (VDJ deleted) reached the pre-B cell surface in relatively high levels even in λ5-deficient SCID mice. A cell surface distribution pattern indicative of receptor aggregation may account for the constitutive activation signal delivery by the truncated μ protein.
27. Sanz E, De la Hera A. A novel anti-Vpre-B antibody identifies immunoglobulin-surrogate receptors on the surface of human pro-B cells. J Exp Med. 183:1996;2693-2698.
28. Papavasiliou F, Jankovic M, Suh H, Nussenzweig MC. The cytoplasmic domains of immunoglobulin (Ig) α and Igβ can independently induce the precursor B cell transition and allelic exclusion. J Exp Med. 182:1995;1389-1394.
29. of special interest Torres RM, Flaswinkel H, Reth M, Rajewsky K. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science. 272:1996;1804-1808 Gene targeting was used to delete most of the cytoplasmic tail of Igα, resulting in an Igα/Igβ heterodimer that allows the assembly and transport of pre-BCRs and BCRs, but is defective for Igα-mediated signaling. B cell generation in the bone marrow was inhibited only two- to four-fold, findings consistent with those in [28], which showed that the cytoplasmic domains of Igα and Igβ can independently induce early B cell development. There was a dramatic decrease in peripheral B cells, however, suggesting a developmental checkpoint that prevents cells with defective receptors from exiting the bone marrow.
30. Soares M, Havaux X, Nisol F, Baxin H, Latinne D. Modulation of rat B cell differentiation in vivo by the administration of an anti-μ monoclonal antibody. J Immunol. 156:1996;108-118.
31. + cells following a single injection of anti-IgM antibody early in gestation. Immunology. 88:1996;28-34.
32. of special interest Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635-638 The PBSF/SDF-1 chemokine, which is constitutively expressed by bone-marrow-derived stromal cells and induces proliferation of B cell progenitors, was ablated by gene-targeting. The number of pro-β cells and pre-B cells was decreased in the liver and bone marrow of the mutant embryonic mice, indicating that PBSF/SDF-1 is essential for B lymphopoiesis and probably acts earlier than IL-7, which affects expansion of pre-B but not pro-B cells in knockout models. Myeloid progenitors were reduced only in the bone marrow, not the fetal liver, suggesting that the PBSF/SDF-1 chemokine may promote homing of hemopoietic precursors to the embryonic bone marrow.
33. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heare J-M, Clark-Lewis I, Legler DF, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
34. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
35. Bleul CC, Fuhlbrigge RC, Casanovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 184:1996;1101-1109.
36. - cells undergo B lineage commitment, differentiation and expansion without IL-7. Neither the addition of IL-7 nor the addition of neutralizing anti-IL-7 antibodies affected B cell development in these cultures. These findings contrast with the essential role for IL-7 in mouse B cell development, as also shown by species differences in the phenotype of XSCID [57,58].
37. of special interest Billips LG, Nuñez CA, Bertand FE III, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med. 182:1995;973-982 IL-7 treatment of human pro-B cells was shown to enhance CD19 expression and downregulate RAG-1, RAG-2, and TdT expression. Cross-linkage of CD19 blocked the IL-7-induced downregulation of RAG but not of TdT. One function of IL-7, therefore, could be to confine N sequence addition primarily to the CDR3 of HCs. Interaction of the upregulated CD19 with a putative ligand on bone marrow stromal cells would maintain RAG activity and completion of Ig gene rearrangements.
38. Hirayama F, Lyman SD, Clark SC, Ogawa M. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood. 85:1995;1762-1768.
39. Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol. 156:1995;489-496.
40. Namikawa R, Muench MO, De Vries JE, Roncarolo M-G. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vivo. Blood. 87:1996;1881-1890.
41. Ray RJ, Paige CJ, Furlonger C, Lyman SD, Rottapel R. Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7. Eur J Immunol. 26:1996;1504-1510.
42. Veiby OP, Lyman SD, Jacobsen SEW. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood. 88:1996;1256-1265.
43. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 3:1995;147-161.
44. Wang J, Lin Q, Langston H, Cooper MD. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity. 3:1995;475-484.
45. Fauteux LJ, Osmond DG. IL-1 as a systemic modifier of B lymphopoiesis: recombinant IL-1α binds to stromal cells and sinusoid endothelium in bone marrow and perturbs precursor B cell dynamics. J Immunol. 156:1996;2376-2383.
46. Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol. 155:1995;3409-3417.
47. Montecino-Rodriguez E, Clark R, Johnson A, Collins L, Dorshkind K. Defective B cell development in snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J Immunol. 157:1996;3334-3340.
48. of special interest Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50 B cell development and activation was examined in transgenic mice that overexpressed human CD19, or in knockout mice incapable of CD19 expression. Early B cell development was unaffected by the absence of CD19, but quantitative differences in CD19 signaling had dramatic effects on later stages. Mice that overexpress CD19 are deficient in newly formed bone marrow B cells, but have elevated levels of serum Ig because the B cells generated are hyper-responsive. CD19-deficient mice are hypogammaglobulinemic and have a significant reduction in peripheral B cells, particularly peritoneal B cells, a phenotype seen also in the CD19 knockout described in [49].
49. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
50. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Muller S, Kantor AB, Herzenberg LA, et al. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
51. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ, Maliszewski CR, Witte ON, Perlmutter RM. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 3:1995;301-312.
52. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:1995;470-473.
53. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374:1995;467-470.
54. + B cells. Eur J Immunol. 26:1996;2537-2540.
55. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, et al. RAG mutations in human B cell-negative SCID. Science. 274:1996;97-99.
56. Yel L, Minegishi Y, Coustan-Smith E, Buckley RH, Trubel H, Pachman LM, Kitchingman GR, Campana D, Rohrer J, Conley ME. Mutations in the Mu heavy-chain gene in patients with agammaglobulinemia. New Eng J Med. 335:1996;1486-1493.
57. Leonard WJ, Noguchi M, Russell SM. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). Adv Exp Med Biol. 365:1994;225-232.
58. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:1995;223-238.
59. Nosaka T, Van Deuiirsen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN. Defective lymphoid development in mice lacking Jak3. Science. 270:1995;800-801.
60. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1996;794-797.
61. Russell SM, Tayebi N, Nakjima H, Riedy MC, Roberts JL, Aman MJ, Migone T-S, Noguchi M, Markert ML, Buckley RH, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 270:1995;787-800.
62. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, Oshea JJ, Vezzoni P, Notarangelo LD. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 377:1995;65-68.